These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 17892630)

  • 21. Infections due to vancomycin-resistant Enterococcus faecium resistant to linezolid.
    Gonzales RD; Schreckenberger PC; Graham MB; Kelkar S; DenBesten K; Quinn JP
    Lancet; 2001 Apr; 357(9263):1179. PubMed ID: 11323048
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vancomycin-resistant Enterococcus spp.: validation of susceptibility testing and in vitro activity of vancomycin, linezolid, tigecycline and daptomycin.
    Rathe M; Kristensen L; Ellermann-Eriksen S; Thomsen MK; Schumacher H
    APMIS; 2010 Jan; 118(1):66-73. PubMed ID: 20041873
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cluster of linezolid-resistant Enterococcus faecium ST117 in Norwegian hospitals.
    Hegstad K; Longva JÅ; Hide R; Aasnæs B; Lunde TM; Simonsen GS
    Scand J Infect Dis; 2014 Oct; 46(10):712-5. PubMed ID: 25134650
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antimicrobial activity of mupirocin, daptomycin, linezolid, quinupristin/dalfopristin and tigecycline against vancomycin-resistant enterococci (VRE) from clinical isolates in Korea (1998 and 2005).
    Lee DK; Kim Y; Park KS; Yang JW; Kim K; Ha NJ
    J Biochem Mol Biol; 2007 Nov; 40(6):881-7. PubMed ID: 18047782
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro activity of fosfomycin tromethamine and linezolid against vancomycin-resistant Enterococcus faecium isolates.
    Cilli F; Pullukcu H; Aydemir S; Sipahi OR; Tasbakan M; Turhan A; Ulusoy S
    Int J Antimicrob Agents; 2008 Mar; 31(3):297-8. PubMed ID: 18180144
    [No Abstract]   [Full Text] [Related]  

  • 26. In vitro synergy of daptomycin plus rifampin against Enterococcus faecium resistant to both linezolid and vancomycin.
    Pankey G; Ashcraft D; Patel N
    Antimicrob Agents Chemother; 2005 Dec; 49(12):5166-8. PubMed ID: 16304195
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selection of a teicoplanin-resistant Enterococcus faecium mutant during an outbreak caused by vancomycin-resistant enterococci with the vanB phenotype.
    Kawalec M; Gniadkowski M; Kedzierska J; Skotnicki A; Fiett J; Hryniewicz W
    J Clin Microbiol; 2001 Dec; 39(12):4274-82. PubMed ID: 11724832
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Linezolid-resistant enterococci in Greece: epidemiological characteristics.
    Spiliopoulou I; Damani A; Chini V; Zerva L; Kolonitsiou F; Anastassiou ED; Petinaki E
    Chemotherapy; 2011; 57(3):181-5. PubMed ID: 21474928
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacodynamics of early, high-dose linezolid against vancomycin-resistant enterococci with elevated MICs and pre-existing genetic mutations.
    Tsuji BT; Bulitta JB; Brown T; Forrest A; Kelchlin PA; Holden PN; Peloquin CA; Skerlos L; Hanna D
    J Antimicrob Chemother; 2012 Sep; 67(9):2182-90. PubMed ID: 22685161
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Resistance to linezolid: characterization of mutations in rRNA and comparison of their occurrences in vancomycin-resistant enterococci.
    Prystowsky J; Siddiqui F; Chosay J; Shinabarger DL; Millichap J; Peterson LR; Noskin GA
    Antimicrob Agents Chemother; 2001 Jul; 45(7):2154-6. PubMed ID: 11408243
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Emerging linezolid-resistant, vancomycin resistant Enterococcus faecium from a patient of a haematological unit in Poland.
    Krawczyk B; Samet A; Bronk M; Hellmann A; Kur J
    Pol J Microbiol; 2004; 53(3):193-6. PubMed ID: 15702920
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparative in-vitro evaluation of resistance selection after exposure to teicoplanin, vancomycin, linezolid and quinupristin-dalfopristin in Staphylococcus aureus and Enterococcus spp.
    Drago L; Nicola L; De Vecchi E
    Clin Microbiol Infect; 2008 Jun; 14(6):608-11. PubMed ID: 18397336
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Linezolid-resistant Enterococcus faecium and Enterococcus faecalis isolated from a septic patient: report of first isolates in Germany.
    Halle E; Padberg J; Rosseau S; Klare I; Werner G; Witte W
    Infection; 2004 Jun; 32(3):182-3. PubMed ID: 15188081
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spread of ampicillin/vancomycin-resistant Enterococcus faecium of the epidemic-virulent clonal complex-17 carrying the genes esp and hyl in German hospitals.
    Klare I; Konstabel C; Mueller-Bertling S; Werner G; Strommenger B; Kettlitz C; Borgmann S; Schulte B; Jonas D; Serr A; Fahr AM; Eigner U; Witte W
    Eur J Clin Microbiol Infect Dis; 2005 Dec; 24(12):815-25. PubMed ID: 16374593
    [TBL] [Abstract][Full Text] [Related]  

  • 35. First report of a linezolid- and vancomycin-resistant Enterococcus faecium strain in Korea.
    Bae HG; Sung H; Kim MN; Lee EJ; Koo Lee S
    Scand J Infect Dis; 2006; 38(5):383-6. PubMed ID: 16709544
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Emergence of linezolid resistance in Enterococcus faecium not dependent on linezolid treatment.
    Bonora MG; Ligozzi M; Luzzani A; Solbiati M; Stepan E; Fontana R
    Eur J Clin Microbiol Infect Dis; 2006 Mar; 25(3):197-8. PubMed ID: 16498524
    [No Abstract]   [Full Text] [Related]  

  • 37. Nosocomial outbreak of vancomycin-resistant Enterococcus faecium in a paediatric unit at a Turkish university hospital.
    Ergani-Ozcan A; Naas T; Baysan BO; Ogunc D; Inan D; Colak D; Nordmann P
    J Antimicrob Chemother; 2008 May; 61(5):1033-9. PubMed ID: 18319236
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antimicrobial activity of linezolid combined with minocycline against vancomycin-resistant Enterococci.
    Wu J; Jiang TT; Su JR; Li L
    Chin Med J (Engl); 2013 Jul; 126(14):2670-5. PubMed ID: 23876894
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro activity of linezolid & quinupristin/dalfopristin against Gram-positive cocci.
    Tünger A; Aydemir S; Uluer S; Cilli F
    Indian J Med Res; 2004 Dec; 120(6):546-52. PubMed ID: 15654141
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Zyvox Annual Appraisal of Potency and Spectrum program: linezolid surveillance program results for 2008.
    Jones RN; Ross JE; Bell JM; Utsuki U; Fumiaki I; Kobayashi I; Turnidge JD
    Diagn Microbiol Infect Dis; 2009 Dec; 65(4):404-13. PubMed ID: 19913683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.